In this review, we summarize the current knowledge of CD8+ T cell responses in cHCV infection and HCC with a special focus on their respective failure and the open questions since this sets the basis for the design of new or additive therapeutic strategies aiming at improving anti-viral and anti-tumoral CD8+ T cell responses. Here, CD8A is linked to hepatocellular carcinoma.